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Computational cardiologyAbstract For several decades, cardiovascular disease has been the leading cause of death through-
out all countries. There is a strong genetic component to many disease subtypes (e.g., cardiomyopa-
thy) and we are just beginning to understand the relevant genetic factors. Several studies have
related RNA splicing to cardiovascular disease and circular RNAs (circRNAs) are an emerging
player. circRNAs, which originate through back-splicing events from primary transcripts, are resis-
tant to exonucleases and typically not polyadenylated. Initial functional studies show clear pheno-
typic outcomes for selected circRNAs. We provide, for the first time, a comprehensive catalogue of
RNase R-resistant circRNA species for the adult murine heart. This work combines state-of-the-art
circle sequencing with our novel DCC software to explore the circRNA landscape of heart tissue.
Overall, we identified 575 circRNA species that pass a beta-binomial test for enrichment (false dis-
covery rate of 1%) in the exonuclease-treated sequencing sample. Several circRNAs can be directly
attributed to host genes that have been previously described as associated with cardiovascular
disease. Further studies of these candidate circRNAs may reveal disease-relevant properties or func-
tions of specific circRNAs.Introduction
Circular RNAs (circRNAs) are a recently-rediscovered RNA
class, which were initially described as ‘‘scrambled” exons in
the early 1990s [1]. Those structures of out-of-order exons
may either result from tandem exon duplications, trans-
splicing, or joining splice donor and acceptor sites of a
transcript, thus creating a circular construct. In 2013, severalnces and
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outcome after circRNA perturbation and sparked enormous
interest in this molecular species [2–4]. Since then, a plethora
of manuscripts on circRNA predictions in various contexts
has appeared in the literature. circRNAs are typically identi-
fied in rRNA-depleted sequencing samples as back-splicing
events [5] that break the collinearity between RNA and
DNA sequences. However, this necessary condition is not
sufficient to prove circularity of the RNA species, since
‘‘scrambled exons” may also arise from trans-splicing and
tandem duplications as mentioned above, genomic alterations,
or simply from read mapping artefacts [6].
The identification and quantification of circRNAs from
next-generation sequencing (NGS) data is an area of ongoing
research. The ‘‘circSeq” approach is the current gold standard
for high-throughput circRNA identification [7]. Briefly,
circRNAs are resistant to exonuclease treatment, whereas
linear RNAs are selectively depleted with this approach. An
untreated control sample and an RNase R-treated sample
are subjected to RNA-seq and contrasted with one another.
Although circSeq is the current gold standard, it may not work
equally well on all circRNAs. For instance, CDR1as/ciRS-7
could not be enriched with RNase R treatment [8].
Relative abundance changes in circRNA expression are
typically approximated by comparing normalized back-splice
junction read counts of specific circRNAs under different con-
ditions and/or time points [9]. Moreover, we recently presented
a statistical framework to detect host gene-independent
circRNA expression changes from sequencing data [10].
It is widely assumed that circRNAs belong to the growing
group of non-coding RNAs (ncRNAs) that encompasses
microRNAs (miRNAs), long ncRNAs (lncRNA), or small-
interfering RNAs (siRNA). Intriguingly, a recent study in
endothelial cells showed that circRNAs are regulated in
response to hypoxia and have a biological function as proven
by in vitro experiments [11]. Nonetheless, no rigorous reports
have been published on circRNAs in murine or human heart
cell types. An extrapolation from other tissue or cell type data
is not possible as previous analyses have clearly demonstrated
that a large proportion of circRNAs are cell type specific [12].
In this manuscript, we aim to provide a catalogue of vali-
dated circRNA species in the adult murine heart. To this
end, we employ the latest developments in bioinformatics
and sequencing technology, and relate our catalogue to
previously-identified cardiomyopathy-related genetic loci.Table 1 Selection of 8 significant circRNAs linked to certain types of
Chr Start End Gene Locus Ensemb
13 11759671 11785141 Ryr2 GRCm38:CM001006.2 ENSMU
12 51772274 51772705 Hectd1 GRCm38:CM001005.2 ENSMU
9 101125023 101153874 Ppp2r3a GRCm38:CM001002.2 ENSMU
1 134834435 134842733 Ppp1r12b GRCm38:CM000994.2 ENSMU
11 4517741 4531305 Mtmr3 GRCm38:CM001004.2 ENSMU
17 81428182 81445593 Slc8a1 GRCm38:CM001010.2 ENSMU
X 83878047 83887233 Dmd GRCm38:CM001013.2 ENSMU
2 76803293 76818816 Ttn GRCm38:CM000995.2 ENSMU
Note: The exact position of each locus is given in terms of chromosome, st
false discovery rate of 1%. BH, Benjamini–Hochberg; Ryr2, ryanodine recep
Ppp2r3a, protein phosphatase 2, regulatory subunit B; Ppp1r12b, protein p
protein 3; Slc8a1, solute carrier family 8 (sodium/calcium exchanger), memResults and discussion
Total RNA was extracted from hearts of adult mice which
were 2, 3, 6, or 12 months old. After depletion of rRNA,
each RNA sample was split into two fractions with one
treated with RNase R (RNase R+) and the other left
untreated (RNase R) (see Methods). No polyA-containing
RNA removal step was carried out, in accordance with other
recent reports on fragment-based circRNA detection [7] and
due to the fact that otherwise no comparison of linear
transcript counts to circular counts would be possible. We
prepared cDNA libraries from these 8 samples and sequenced
them on an Illumina HiSeq 2500. The corresponding read
coverage tracks have been compiled into a publicly-
available TrackHub for the UCSC Genome Browser [13]
(Supplementary online data).
575 circRNAs are significantly enriched
The DCC software [10] was used to identify circRNA candi-
dates from chimeric read mappings (see Materials and Meth-
ods). This initial step yielded 8375 potential circRNA
regions. We subsequently employed the circTest suite in
DCC [10] to confine the search to 741 circRNA loci by filtering
for consistent read support and a minimal proportion of
junction-spanning reads (1%). Lastly, we tested enrichment
of back-splicing in read sets of RNase R+ in comparison to
RNase R samples and further reduced the candidate
circRNA set to 575 circRNAs (Table S1). We additionally
screened the catalogue of the 575 significant circRNAs for
alternative splicing using the DCC output files and found only
2.4% having >3 supporting reads for alternative splicing
variants.
Table 1 shows an example of 8 selected circRNAs that are
localized in cardiovascular disease-related gene loci. circTest
generates enrichment plots for each of the significant
circRNAs (BH corrected P values, FDR 1%). Due to the
employed circle sequencing approach, RNase R and RNase
R+ samples should be clearly separated within the enrichment
plot since the RNase R digestion step removes the bulk of lin-
ear transcripts and more sequencing reads actually cover
circRNAs structures instead of linear transcripts in the
untreated sample. Therefore, this graphical representation is
a first quality measurement for the success of enrichmentcardiovascular disease
l ID BH corrected P value Linked disease Ref.
SG00000021313 9.35E07 Hypertension [14]
SG00000035247 1.72E06 Cardiomyopathy [15]
SG00000043154 3.88E06 Cardiomyopathy [16]
SG00000073557 0.00001 Coronary heart disease [17]
SG00000034354 0.00001 Coronary heart disease [18]
SG00000054640 0.00001 Cardiomyopathy [19]
SG00000045103 0.00002 Cardiomyopathy [20]
SG00000051747 0.00002 Cardiomyopathy [21]
art and stop position. circRNAs were evaluated by using circTest with
tor 2; Hectd1, HECT domain-containing E3 ubiquitin protein ligase 1;
hosphatase 1, regulatory subunit 12B; MTMR3, myotubularin-related
ber 1; Dmd, dystrophin; Ttn, titin.
218 Genomics Proteomics Bioinformatics 14 (2016) 216–223process. In an ideal experiment all linear fragments in the
RNase R treated sample should be digested, leaving only circu-
lar constructs in the sample. A drastic increase of reads cover-
ing circRNAs would therefore be expected when comparing
untreated and treated samples. Also this ideal situation does
not translate exactly to practice. The enrichment plots in
Figure 1 show that the enrichment process performed well
for all samples, thus confirming the gold standard of circle
sequencing.Figure 1 Comparison of the enrichment for circRNAs in RNase R+ a
The 8 most significant circRNAs assessed by circTest and linked to c
values, FDR 1%). circTest uses the beta binomial distribution to mo
differ in their relative expression between the groups. Due to the impl
treated as 4 replicates (n= 4) for RNase R treated (RNase R+) and un
the mean. Therefore, changes in expression at all 4 time points are take
ryanodine receptor 2;Hectd1, HECT domain-containing E3 ubiquitin p
B; Ppp1r12b, protein phosphatase 1, regulatory subunit 12B; MTMR
(sodium/calcium exchanger), member 1; Dmd, dystrophin; Ttn, titin.Inspection of the most significant circRNAs
The vast majority of circRNAs were only found at only one
location within the annotated gene regions (97.6%, threshold:
3 supporting reads). For the remaining 2.4% circRNAs, more
than 3 reads were found at a secondary location within the
annotated gene regions; however, hardly more than 10 reads
were detected at the secondary locations for these circRNAs.
Therefore, circRNAs seem to be predominantly emerging fromnd RNase R samples
ertain types of cardiovascular disease are shown (BH corrected P
del the data and performs an ANOVA to identify circRNAs that
ementation of circTest, the 4 time points for the same samples are
treated (RNase R) samples. Error bars show the standard error of
n into account when calculating the host gene independence. Ryr2,
rotein ligase 1; Ppp2r3a, protein phosphatase 2, regulatory subunit
3, myotubularin-related protein 3; Slc8a1, solute carrier family 8
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circRNAs identified above, we selected the top three most
significant loci, Ryr2, Hectd1, and Ppp2r3a that encode
ryanodine receptor 2, HECT domain-containing E3 ubiquitin
protein ligase 1, and protein phosphatase 2, regulatory subunit
B, respectively, for further inspection.
The annotated genomic region of Ryr2, throughout all
experiments, showed the most significant enrichment in
general (Table 1, Figure 1). The combination of expressionFigure 2 Detailed view of five selected genes strongly related to cardi
The ratio is calculated as (raw count of mapped reads for transcript in s
(B), Dmd (C), Ppp2r3a (D), and Hectd1 (E).level, enrichment compared to the remaining linear RNAs
reported by circTest (Figure 2), and its involvement in
arrhythmias make Ryr2 circRNA a very promising
candidate for further analyses. The circRNA for Ryr2 is
roughly located between the second and last third of
the annotated gene region (Figure 3). The RNase R
circRNA candidate reads cover a region of 6 exons and
5 introns, starting at exon 24 and up to exon 29 of
25 kb in length.ovascular disease
ample/raw count of total reads in sample) * 1000) for Ryr2 (A), Ttn
Figure 3 Ensembl screen shot of the circRNA locus linked to the Ryr2 gene
The region covered by the circRNA locus is defined by the red rectangle, which measures around 25 kb and covers 6 exons of Ryr2. Mouse
genome is shown as black/white line and tracks depict the exon/intron structure of the gene.
220 Genomics Proteomics Bioinformatics 14 (2016) 216–223The locus of the Hectd1 circRNA spans only 432 bp. The
fragment spans only 2 exons (namely exon 23 and exon 24)
and is located within the last third of Hectd1 coding region
(Figure 4). Hectd1 circRNA belongs to the class of relatively
small circRNAs. Notwithstanding, it is one of the most
significant circRNAs in our samples.Figure 4 Ensembl screen shot of the circRNA locus linked to the Hec
The region covered by the circRNA locus is defined by the red dotted
depict the exon/intron structure of the gene.In contrast, the identified circRNA locus of Ppp2r3a again
measures more than 28 kb and contains 6 exons, starting from
exon 6 and ranging up to exon 12. Due to the small size of
Ppp2r3a, the 28 kb circRNA makes up nearly a quarter
of the gene’s length and is located in the last quarter of the
annotated gene region (Figure 5).td1 gene
line. Mouse genome is shown as black/white line below and tracks
Figure 5 Ensembl screen shot of the circular RNA locus linked to the Ppp2r3a gene
The region covered by the circRNA locus is defined by the red rectangle, which measures around 25 kb and covers 6 exons of Ppp2r3a.
Mouse genome is shown as black/white line below and tracks depict the exon/intron structure of the gene.
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circRNAs are known to be highly specific to tissue and devel-
opmental status of the cell [12]. An in-depth analysis of highly-
abundant circRNAs disclosed several genes tightly linked to
functions of cardiomyocytes. Due to the selection of heart
tissue and our focus on cardiovascular disease, we focused
on three genes tightly coupled to cardiomyocytes and car-
diomyopathy, Ryr2, Ttn, and Dmd for scrutinization.
These candidate genes are known to play key roles in differ-
ent kinds of cardiomyopathy such as Dmd-associated dilated
cardiomyopathy, arrhythmogenic right ventricular cardiomy-
opathy (ARVC) (Ryr2), or hypertrophic cardiomyopathy
(HCM, Ttn), and therefore are central parts of the respective
KEGG pathways (mmu05414, mmu05410, and mmu05412)
[22].
There is an overwhelming presence of Ryr2 circRNAs
regardless of the age of the murine heart examined (Figure 2A).
Primarily expressed in cardiomyocytes, Ryr2 encodes ryan-
odine receptor 2 (RYR2), which is a sarcoplasmic reticulum
membrane-embedded transport protein for Ca2+ and is
responsible for the rhythmic muscle contractions generating
the heartbeat [14]. The abundance of Ryr2 circRNAs is rela-
tively constant for all 4 time points, which peaks at month 6.
Traces of Ryr2 circRNA are detectable even without the
enrichment step, whereas after enrichment the abundance is
2–3 times higher when compared to the untreated sample.
The detection of Ttn fits in the same picture, as it is respon-
sible for the passive elasticity of muscles and therefore plays a
critical role in heart muscle cells [21]. circRNA abundance of
Ttn generally follows the pattern of Ryr2 albeit with relativelymodest changes. In comparison, the enrichment process was
not as successful as for Ryr2, as higher circRNA counts were
detected for month 4 and month 6 in the untreated samples
than the treated samples. For example, very long circRNA
molecules may get nicked or sheared during the isolation pro-
cess, making them sensitive to RNAse R treatment.
Dmd-associated dilated cardiomyopathy is directly linked
to mutations in the Dmd gene [20]. Therefore, Dmd circRNA
could be another valuable target for cardiomyopathy research.
The expression pattern of Dmd circRNA differs from those of
Ryr2 and Ttn, demonstrating maximal expression for month
12 instead of month 6. We achieved non-optimal enrichment
for circRNAs from mice aged 3 or 6 months, possibly due to
portions of the circRNAs lost during the RNase R digestion
process.
The pattern of abundance of circRNAs for all three genes
may be influenced by the age and activity of the mice. While
the linear transcripts Ryr2 and Ttn may be more connected to
young and active hearts, Dmd-encoded protein strengthens the
cardiomyocyte sarcolemmal integrity, and its maximal expres-
sion may be important for optimal function (hemodynamic
and stress responses) of the fully developed, mature adult heart.
Although the described properties are related to the protein-
coding linear transcripts, their corresponding circRNAs may
be involved in those diseases directly or indirectly.
Conclusion
In this work we present circle sequencing as a highly efficient
and sensitive tool for circRNA studies in cardiology. In sum-
mary, we compiled a catalogue of 575 candidate circRNAs
222 Genomics Proteomics Bioinformatics 14 (2016) 216–223that pass a test for enrichment in RNase R-treated samples in
comparison to untreated samples using circTest. Many of these
candidates coincide with disease-associated gene loci. For
instance, significant candidates originate from the Ryr2,
Hectd1, and Ppp2r3a gene loci that have been linked to
cardiovascular disease.
As a long term goal, how these circRNAs might influence
cell processes in disease-related phenotypes and healthy tissue
needs to be addressed. Furthermore, more efforts are also
needed as to how this information may translate into new
treatment approaches of cardiovascular disease.Materials and methods
Circle sequencing
Total RNA extracted from heart tissue of CD1-strain mice of
ages 2, 3, 6, and 12 months was commercially acquired from
AMS Biotechnology (Abingdon, Oxfordshire, UK). The
rRNA depletion step was carried out with 20 lg of total
RNA using the Ribo-Zero Magnetic Kit (Human, Mouse,
Rat; Epicentre, Madison, WI, United States) and 5 lg input
per reaction. Depletion was performed in parallel, followed
by subsequent pooling. For digestion of linear RNA, 3 quar-
ters of the depleted RNA was treated with RNase R, whereas
the remaining one quarter of the depleted RNA only received
water and acts as a negative control. Both samples were treated
equally for all further steps. After heating to 70 C and cooling
to 35 C, 10 RNase R reaction buffer and RNase R (Epicen-
tre; Cat No. RNR07250) were added to the 3-quarter fraction,
followed by heating to 37 C for 40 min. Samples were cleaned
up using Agencourt RNAClean XP beads (Beckman Coulter
GmbH, Krefeld, North Rhine-Westphalia, Germany). Subse-
quent library preparation was performed with ScriptSeq-v2
RNA-Seq Library Preparation Kit (Epicentre). PCR amplifi-
cation was performed with 15 cycles, without any further size
selection. Sequencing was carried out on an Illumina
HiSeq2500 system for 100 cycles using paired-end mode.
Sequence data were deposited in the NCBI Sequence Read
Archive (SRA) with the accession number SRP071584.
Bioinformatics analyses
Paired-end rRNA-depleted sequencing data of RNase R trea-
ted and untreated samples were analysed in detail. After initial
quality assessment, low quality regions and adapter sequences
were removed with Flexbar (version 2.5) [23]. Read mapping
against the mouse reference genome build mm10 was per-
formed with the STAR aligning software (version 2.4.2a) [24].
To optimally exploit the advantage of the circSeq tech-
nique, we have developed the DCC software to efficiently
detect and quantify circRNAs in sequencing data [10]. DCC
software computes expression levels of host genes and
circRNAs and allows for tests of circRNA expression indepen-
dent of linear host genes even across several experimental
conditions and replicates. DCC analysis took place with
version 0.3.2 using the parameters ‘‘-M -Nr 2 2 -fg -G -F -L
20”. Further statistical analyses were performed with the
circTest R package provided with DCC and additional
custom-tailored Perl scripts.Authors’ contributions
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